Leveraging electronic patient-reported outcomes collected at six cancer centers to identify symptom clusters across the first four weeks of chemotherapy.

Authors

null

Rachel A. Pozzar

Dana-Farber Cancer Institute, Boston, MA

Rachel A. Pozzar, Angela Tramontano, Christine Cronin, Michael J. Hassett, Deborah Schrag, Raymond U. Osarogiagbon, Hannah W. Hazard-Jenkins, Jessica J Bian, Sandra L. Wong, Don S. Dizon, Alexi A. Wright

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Symptom Prevention, Assessment, and Management

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 366)

DOI

10.1200/OP.2023.19.11_suppl.366

Abstract #

366

Poster Bd #

F23

Abstract Disclosures

Similar Posters

First Author: Akhil Kapoor

Poster

2017 ASCO Annual Meeting

Fosaprepitant use in children and adolescents at Memorial Sloan Kettering Cancer Center.

Fosaprepitant use in children and adolescents at Memorial Sloan Kettering Cancer Center.

First Author: Dazhi Liu

First Author: Tian Qi Wang